Syncona — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Clade Therapeutics inNov 2021 · $87M

BiotechCambridge, US

Chad A. Cowan(Executive Officer, Director)inLeandro Vetcher(Executive Officer)Daniel Vasella(Director)Jim Glasheen(Executive Officer, Director)Neil White(Director)

BoardMartin Murphy(Director)

Co-investorsLifeSci Venture Partners Bain Capital Life Sciences Casdin Capital Venrock Healthcare Capital Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Gyroscope Therapeutics Ltd

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.